Large area microwave plasma chemical vapour deposition (la mpcvd) reactor apparatus and method for providing same
EP3560516A1
Combination therapy including beta-sitosterol in combination with at least one of a braf inhibitor, a mek inhibitor or an erk inhibitor and methods and use thereof
WO2018197858A1
Microstructured sapphire substrates
EP3524625A1
Antibody against alpha-11 integrin and its use
EP3517549A1
Antibody against alpha-11 integrin and its use
WO2018087522A1
Neutral-beam microscopy
WO2018078145A1
Novel immunotherapeutic treatments for tumours
EP3475305A1
Anti-axl antagonistic antibodies
US2014327760A1
Method of investigating a solid sample
EP2614823A1
Use of triazolylpiperidine derivatives
EP2649198A1
Marker for carcinoma
EP2599789A1
Marker and method for diagnosing diarrhea syndrome
WO2012010661A1
Methods for determining a prognosis for survival for a patient with leukaemia
EP2465848A1
Triazolylpiperidine derivatives and method for making the same
EP2446893A1
Use of nontoxic cyclic peptides to block transport via OATP1B1/ OATP1B3-related proteins, for the treatment of cancer cells expressing such transporters
WO2010094697A1
Liquefaction of lignin with gaseous components
WO2010085153A1
Methods for determining a prognosis for survival for a patient with breast cancer
